Current Opinion in Nephrology and Hypertension

Article	Citations
Membranous nephropathy: current understanding of various causes in light of new target antigens	31
Microbiome modulation as a novel therapeutic approach in chronic kidney disease	28
Depression in dialysis	23
Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease	23
New insights into muscle function in chronic kidney disease and metabolic acidosis	21
Novel conservative management of chronic kidney disease via dialysis-free interventions	21
Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients	20
Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes	20
The genetic spectrum of Gitelman(-like) syndromes	18
Disparities in chronic kidney disease-the state of the evidence	18
Ageing, cellular senescence and chronic kidney disease: experimental evidence	18
Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy	16
Novel approaches to management of hyperkalaemia in kidney transplantation	15
The epidermal growth factor receptor axis and kidney fibrosis	15
Plasma and urine biomarkers in chronic kidney disease: closer to clinical application	15
The « race » correction in estimating glomerular filtration rate: an European point of view	15
Recent advances in dialysis membranes	15
How common is primary aldosteronism?	14
Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension	14
Sodium bicarbonate therapy for acute respiratory acidosis	14
The clinical application of frailty in nephrology and transplantation	14
Precision medicine approach to dialysis including incremental and decremental dialysis regimens	13
Application of dynamic contrast enhanced ultrasound in the assessment of kidney diseases	13
Hypernatremia in the intensive care unit	12
Chimerism and tolerance: past, present and future strategies to prolong renal allograft survival	12

Pathogenesis of coronavirus disease 2019-associated kidney injury	11
Gut microbiome, parathyroid hormone, and bone	11
Contribution of Th17 cells to tissue injury in hypertension	11
Cardiovascular autonomic nervous system dysfunction in chronic kidney disease and end-stage kidney disease: disruption of the complementary forces	11
New therapeutics for primary hyperoxaluria type 1	11
Diagnosis of amyloid beyond Congo red	11
The impact of advanced glycation end products on bone properties in chronic kidney disease	11
B-cell depletion or belimumab or voclosporin for lupus nephritis?	11
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis	11
The potential of artificial intelligence-based applications in kidney pathology	10
Gut–brain–bone marrow axis in hypertension	10
Cystic fibrosis in the kidney: new lessons from impaired renal HCO3− excretion	10
TaleNeprilysin and Neprilysin inhibition in chronic kidney disease	10
Fluid administration strategies for the prevention of contrast-associated acute kidney injury	10
Targeting inflammation in hypertension	10
Cardiovascular disease in children with chronic kidney disease	10
Apolipoprotein L1 and mechanisms of kidney disease susceptibility	10
The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease	10
Treatment potential in APOL1-associated nephropathy	10
Clinical utility of bone turnover markers in patients with chronic kidney disease	9
Novel intestinal dialysis interventions and microbiome modulation to control uremia	9
Lifestyle interventions for preventing and ameliorating CKD in primary and secondary care	9
Mechanisms of leptin-induced endothelial dysfunction	9
Novel approaches to sarcopenic obesity and weight management before and after kidney transplantation	9
SNF472: mechanism of action and results from clinical trials	9
Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one	8
Hypoxia-inducible factor prolyl hydroxylase enzyme inhibitors: ready for primetime?	8
Managing hyperuricemia and gout in chronic kidney disease: a clinical conundrum	8
Recent evidence on the effect of urate-lowering treatment on the progression of kidney disease	8
Intestinal phosphorus absorption: recent findings in translational and clinical research	8
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease	8
Coronavirus disease 2019 and kidney injury	8
Neglected analytes in the 24-h urine: ammonium and sulfate	8
Electrolytes disturbances in cancer patients	8
Healthy and unhealthy aging on kidney structure and function: human studies	7
Lipocalin-2: a novel link between the injured kidney and the bone	7
Revisiting diuretic choice in chronic kidney disease	7
Cellular therapies in kidney transplantation	7
Angiotensin-converting enzyme 2: from a vasoactive peptide to the gatekeeper of a global pandemic	7
Role of artificial intelligence in the diagnosis and management of kidney disease: applications to chronic kidney disease and acute kidney injury	7
Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review	7
Emerging non-pharmacological interventions in ADPKD: an update on dietary advices for clinical practice	7
Editorial: Novel therapeutic approaches in chronic kidney disease, uremia and kidney transplantation: past, present and future	7
Regulation of renal pendrin activity by aldosterone	7
Redlining has led to increasing rates of nephrolithiasis in minoritized populations: a hypothesis	7
Sex differences in renal electrolyte transport	7
Gut–kidney axis in oxalate homeostasis	6
Revisiting glomerular hyperfiltration and examining the concept of high dietary protein-related nephropathy in athletes and bodybuilders	6
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	6
Great nephrologists begin with great teachers: update on the nephrology curriculum	6

Maximizing opportunities for kidney transplantation in older adults	6
Climate change and kidney stones	6
Communication principles and practices for making shared decisions about renal replacement therapy: a review of the literature	6
Indications for and results of renal autotransplantation	6
Complement and kidney disease, new insights	6
Novel management of diabetes in kidney transplantation	6
Novel approaches to management of hypertension	6
Role of deceased donor kidney procurement biopsies in organ allocation	6
Sodium-glucose cotransporter 2 inhibition in non-diabetic kidney disease	6
Hypertension in Pregnancy: What We Now Know	6
How to assess quality of life in persons with chronic kidney disease	6
WNK1 in the kidney	6
Novel therapeutic and diagnostic approaches for preeclampsia	5
Novel agents for treating IgA nephropathy	5
Challenges in communication, prognostication and dialysis decision-making in the COVID-19 pandemic: implications for interdisciplinary care during crisis settings	5
Research progress of sirtuins in renal and cardiovascular diseases	5
Fibroblast growth factor 23, klotho and heparin	5
Updated management for antibody-mediated rejection: opportunity to prolong kidney allograft survival	5
Uromodulin: more than a marker for chronic kidney disease progression	5
Collapsing glomerulopathy: unraveling varied pathogeneses	5
Seven suggestions for successful SGLT2i use in glomerular disease - a standalone CKD therapy?	5
Spatial transcriptomics and the kidney	5
Pruritus in chronic kidney disease	5
Nutritional and dietary interventions to prolong renal allograft survival after kidney transplantation	5
Novel monitoring of renal function and medication levels in saliva and capillary blood of patients with kidney disease	5
How to inhibit transforming growth factor beta safely in diabetic kidney disease	5
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker	5
Interaction between sodium-glucose co-transporter 2 and the sympathetic nervous system	5
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	5
Community acquired and hospital acquired AKI - two diseases divided by a common definition	4
Understanding renal phosphate handling: unfinished business	4
Complications after native kidney biopsy: definitive data	4
Point-of-care ultrasound in nephrology	4
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease	4
The expanding spectrum and utility of antigens in membranous nephropathy	4
Alport syndrome and Alport kidney diseases – elucidating the disease spectrum	4
Novel approaches beyond standard immunofluorescence for kidney biopsies	4
Dendritic cell epithelial sodium channel induced inflammation and salt-sensitive hypertension	4
Prospective collagen IVα345 therapies for Alport syndrome	4
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	4
Regulation of vascular tone and blood pressure by singlet molecular oxygen in inflammation	4
Timing of kidney replacement therapy initiation in acute kidney injury	4
Cystatin C should be routinely available for estimating kidney function	4
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	4
Sortilin and hypertension	4
Changing landscape of living kidney donation and the role of telemedicine	4
Complement detection in kidney biopsies – utility and challenges	4
Fifty years of basic and clinical renal stone research: have we achieved major breakthroughs? A debate	4
Modern indications for referral for kidney and pancreas transplantation	4
Bone loss and kidney stone risk in weightlessness	4
Heating up: climate change and the threat to human health	4
Vitamin K and vascular calcification	4
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	4
Advances in management of hepatorenal syndrome	3
A review of the AURORA and BLISS trials: will it revolutionize the treatment of lupus nephritis?	3
Defining improvement in chronic kidney disease: regression and remission	3
Contemporary risk prediction models in chronic kidney disease: when less is more	3
Sodium/glucose cotransporter 2 inhibitors in chronic kidney disease and heart failure: ready for prime time in patients without diabetes	3
Albuminuria, proteinuria, and dipsticks: novel relationships and utility in risk prediction	3
Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant	3
Finerenone: a new mineralocorticoid receptor antagonist to beat chronic kidney disease	3
An update on corticosteroid treatment for IgA nephropathy	3
Novel pharmacological interventions for diabetic kidney disease	3
Chronic kidney disease associated cardiomyopathy: recent advances and future perspectives	3
Management of acute kidney injury associated with Covid-19: what have we learned?	3
Machine learning for risk stratification in kidney disease	3
Physiologic considerations of pig-to-human kidney xenotransplantation	3
Immune checkpoint inhibitors and kidney disease	3
The TMEM16A channel as a potential therapeutic target in vascular disease	3
Efficacy and safety of Sodium-Glucose-Transporter-2 inhibitors in kidney transplant patients	3
Climate change and its influence in nephron mass	3
KCa3.1 in diabetic kidney disease	3
Revisiting the relationship between (Pro)Renin receptor and the intrarenal RAS: focus on the soluble receptor	3
Anemia and fibroblast growth factor 23 elevation in chronic kidney disease: homeostatic interactions and emerging therapeutics	3
Nanomedicine in kidney disease	3
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	3
Bisphosphonates and management of kidney stones and bone disease	3
Medication safety in chronic kidney disease	3
Recent evidence on the effect of treatment of metabolic acid on the progression of kidney disease	3
Gene therapy for kidney disease: targeting cystinuria	3

Eryptosis: a driver of anemia in chronic kidney disease	3
DNA J homolog subfamily B member 9 and other advances in fibrillary glomerulonephritis	3
Contribution of phosphate and FGF23 to CKD progression	3
Urinary extracellular vesicles: does cargo reflect tissue?	3
Applications of cardiac biomarkers in chronic kidney disease	3
Traditions and innovations in assessment of glomerular filtration rate using creatinine to cystatin C	3
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	3
Current opinion in quantitative lung ultrasound for the nephrologist	2
Renal osteodystrophy: something old, something new, something needed	2
Treatment options for managing obesity in chronic kidney disease	2
COVID-19 in patients with glomerular disease	2
Updates in hypertension: new trials, targets and ways of measuring blood pressure	2
Kidney health and function with left ventricular assist devices	2
Paradigm shift in lifestyle modification for solitary kidney after donor nephrectomy	2
Cellular and molecular interrogation of kidney biopsy specimens	2
When a calorie isn’t just a calorie: a revised look at nutrition in critically ill patients with sepsis and acute kidney injury	2
Building kidney organoids from pluripotent stem cells	2
Progress in hepatitis C virus management in chronic kidney disease	2
Kidney lymphatics: new insights in development and disease	2
Building a hemodiafiltration system from readily available components for continuous renal replacement therapy under disasters and pandemics: preparing for an acute kidney injury surge during COVID-19	2
Assessment of microcirculatory function during hemodialysis	2
Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection	2
The role of SLC16A11 variations in diabetes mellitus	2
Identification and detection of microRNA kidney disease biomarkers in liquid biopsies	2
Lipid management to mitigate poorer postkidney transplant outcomes	2
Regulation of the WNK4-SPAK-NCC pathway by the calcium-sensing receptor	2
Glycerol-3-phosphate and fibroblast growth factor 23 regulation	2
Persistent hyperparathyroidism in long-term kidney transplantation: time to consider a less aggressive approach	2
Literature review: are NSAIDs harmful and is acetaminophen well tolerated?	2
Harm! foul! How acute kidney injury SHReDDs patient futures	2
The promise of artificial intelligence for kidney pathophysiology	2
Approach to stable angina in patients with advanced chronic kidney disease	2
Phosphate balance during dialysis and after kidney transplantation in patients with chronic kidney disease	2
Chronic kidney disease with unknown cause across the global spectrum	2
WNK4 kinase: role of chloride sensing in the distal convoluted tubule	2
Combination therapy with kidney protective therapies: optimizing the benefits?	2
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	2
Skin autofluorescence as tool for cardiovascular and diabetes risk prediction	2
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	2
The race coefficient in glomerular filtration rate-estimating equations and its removal	2